Impact of phyto-cannabinoids on the epigenetic regulation of diabetes
Project objectivesTo define the epigenetic effects of natural compounds (phytocannabinoids), commonly used in pharmaceutical formulations against neuroinflammatory diseases. |
Start and end date |
|
2013-2014 |
Project Manager |
|
Prof. Mauro Maccarrone, coordinator |
Coordinating institution of the project |
|
Università Campus Bio-Medico di Roma |
Funding source(s). |
|
GW Pharmaceuticals PLC, London (UK) |